Matches in Wikidata for { <http://www.wikidata.org/entity/Q85089351> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q85089351 description "artículu científicu espublizáu en setiembre de 2010" @default.
- Q85089351 description "scientific article published on 22 September 2010" @default.
- Q85089351 description "wetenschappelijk artikel" @default.
- Q85089351 description "наукова стаття, опублікована у вересні 2010" @default.
- Q85089351 description "գիտական հոդված հրատարակված 2010 թվականի սեպտեմբերի 22-ին" @default.
- Q85089351 name "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization" @default.
- Q85089351 name "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization" @default.
- Q85089351 type Item @default.
- Q85089351 label "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization" @default.
- Q85089351 label "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization" @default.
- Q85089351 prefLabel "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization" @default.
- Q85089351 prefLabel "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization" @default.
- Q85089351 P1433 Q85089351-D844C6E6-9A8E-4708-A521-CAFC55A92630 @default.
- Q85089351 P1476 Q85089351-4318C9A5-EC40-4C12-B591-FD243027D884 @default.
- Q85089351 P2093 Q85089351-2B3AB2AA-EAD6-4688-B1B3-6C6A25463D17 @default.
- Q85089351 P2093 Q85089351-35367D4D-2866-4022-A189-DE54332F5284 @default.
- Q85089351 P2093 Q85089351-3FE712C2-B295-47B6-A5F5-5A736B4CE3A1 @default.
- Q85089351 P2093 Q85089351-692270FA-DFA5-4427-9918-B348FFD99391 @default.
- Q85089351 P2093 Q85089351-6A690601-5689-4390-868F-AAC10BD73B5A @default.
- Q85089351 P2093 Q85089351-A52DA474-9CD7-4094-8C97-14A9C773B5EC @default.
- Q85089351 P304 Q85089351-2A57C9B6-30DD-4E4A-815F-FE757FAADBC9 @default.
- Q85089351 P31 Q85089351-CD8AA748-D34A-407E-9E16-06BEA104F465 @default.
- Q85089351 P356 Q85089351-BA305833-E163-4338-B812-4276B6648A58 @default.
- Q85089351 P433 Q85089351-4531B9BA-4990-4280-8DC6-270DAB3F50A4 @default.
- Q85089351 P478 Q85089351-AC7480B9-69D8-4A08-83DE-9DEAE4D0554E @default.
- Q85089351 P50 Q85089351-972921E7-14C9-4617-965F-0BF9B1393E22 @default.
- Q85089351 P577 Q85089351-4EE1916C-6CEF-4B11-BA88-EB57E4D78CB4 @default.
- Q85089351 P698 Q85089351-366F4262-4298-41B9-978F-2D941FE4ED56 @default.
- Q85089351 P921 Q85089351-328A8772-C207-4E37-9933-F76CCC956630 @default.
- Q85089351 P356 J.JCONREL.2010.09.004 @default.
- Q85089351 P698 20868711 @default.
- Q85089351 P1433 Q6295046 @default.
- Q85089351 P1476 "New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization" @default.
- Q85089351 P2093 "Conrad Coester" @default.
- Q85089351 P2093 "Gerhard Winter" @default.
- Q85089351 P2093 "Nicolas A Geis" @default.
- Q85089351 P2093 "Raffi Bekeredjian" @default.
- Q85089351 P2093 "Steliyan Tinkov" @default.
- Q85089351 P2093 "Susanne Serba" @default.
- Q85089351 P304 "368-372" @default.
- Q85089351 P31 Q13442814 @default.
- Q85089351 P356 "10.1016/J.JCONREL.2010.09.004" @default.
- Q85089351 P433 "3" @default.
- Q85089351 P478 "148" @default.
- Q85089351 P50 Q27929168 @default.
- Q85089351 P577 "2010-09-22T00:00:00Z" @default.
- Q85089351 P698 "20868711" @default.
- Q85089351 P921 Q6839290 @default.